Trexquant Investment’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-186,157
Closed -$1.25M 1934
2025
Q3
$1.25M Buy
186,157
+15,122
+9% +$98.7K 0.01% 1068
2025
Q2
$1.01M Sell
171,035
-121,278
-41% -$790K 0.01% 1102
2025
Q1
$2.45M Sell
292,313
-26,576
-8% -$239K 0.03% 796
2024
Q4
$2.37M Buy
318,889
+21,000
+7% +$141K 0.03% 802
2024
Q3
$1.73M Buy
297,889
+256,125
+613% +$1.65M 0.02% 867
2024
Q2
$278K Sell
41,764
-119,682
-74% -$967K ﹤0.01% 1379
2024
Q1
$2.11M Buy
161,446
+151,100
+1,460% +$2.01M 0.04% 632
2023
Q4
$132K Buy
+10,346
New +$105K ﹤0.01% 1360
2023
Q3
Sell
-16,582
Closed -$424K 1828
2023
Q2
$424K Sell
16,582
-36,335
-69% -$938K 0.01% 1070
2023
Q1
$1.33M Buy
+52,917
New +$1.24M 0.04% 611
2022
Q2
Sell
-24,780
Closed -$469K 1866
2022
Q1
$469K Buy
24,780
+13,775
+125% +$268K 0.02% 794
2021
Q4
$205K Buy
+11,005
New +$227K 0.01% 1137

Other funds holding TMCI

Trexquant Investment's TMCI Position: Q4 2025 in Review

Trexquant Investment sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 186,157 shares — an estimated $1.25M sold.

Trexquant Investment first reported a position in TMCI in Q4 2021 and held it in 12 quarters. The position peaked at $2.45M in Q1 2025. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Trexquant Investment reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 186,157 Treace Medical Concepts shares in Q4 2025, an estimated $1.25M.
  • Trexquant Investment first reported a position in Treace Medical Concepts in Q4 2021 and held it in 12 quarters.
  • Trexquant Investment's Treace Medical Concepts position peaked at $2.45M in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.